Is Ethnic Variability in the Exposure to Rosuvastatin Explained Only by Genetic Polymorphisms in OATP1B1 and BCRP or Should the Contribution of Intrinsic Ethnic Differences in OATP1B1 Be Considered?

被引：9
作者：
Sugiyama, Yuichi [1 ]
Maeda, Kazuya [2 ]
Toshimoto, Kota [1 ]
机构：
[1] RIKEN, Innovat Ctr, Sugiyama Lab, Yokohama, Kanagawa, Japan
[2] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Mol Pharmacokinet, Tokyo, Japan
来源：
JOURNAL OF PHARMACEUTICAL SCIENCES | 2017年 / 106卷 / 09期
关键词：
ASIAN SUBJECTS; PHARMACOKINETICS;
D O I：
10.1016/j.xphs.2017.04.074
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：2227 / 2230
页数：4
相关论文
共 6 条
  • [1] Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?
    Birmingham, Bruce K.
    Bujac, Sarah R.
    Elsby, Robert
    Azumaya, Connie T.
    Wei, Cheryl
    Chen, Yusong
    Mosqueda-Garcia, Rogelio
    Ambrose, Helen J.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (03) : 341 - 355
  • [2] Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment
    Lee, E
    Ryan, S
    Birmingham, B
    Zalikowski, J
    March, R
    Ambrose, H
    Moore, R
    Lee, C
    Chen, YS
    Schneck, D
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (04) : 330 - 341
  • [3] Organic Anion Transporting Polypeptide (OATP)1B1 and OATP1B3 as Important Regulators of the Pharmacokinetics of Substrate Drugs
    Maeda, Kazuya
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (02) : 155 - 168
  • [4] More Power to OATP1B1: An Evaluation of Sample Size in Pharmacogenetic Studies Using a Rosuvastatin PBPK Model for Intestinal, Hepatic, and Renal Transporter-Mediated Clearances
    Riedmaier, Ariane Emami
    Burt, Howard
    Abduljalil, Khaled
    Neuhoff, Sibylle
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 : S132 - S142
  • [5] Ethnic Variability in the Plasma Exposures of OATP1B1 Substrates Such as HMG-CoA Reductase Inhibitors: A Kinetic Consideration of Its Mechanism
    Tomita, Y.
    Maeda, K.
    Sugiyama, Y.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (01) : 37 - 51
  • [6] Rosuvastatin Pharmacokinetics in Asian and White Subjects Wild Type for Both OATP1B1 and BCRP Under Control and Inhibited Conditions
    Wu, Hsin-Fang
    Hristeva, Nadya
    Chang, Jae
    Liang, Xiaorong
    Li, Ruina
    Frassetto, Lynda
    Benet, Leslie Z.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (09) : 2751 - 2757
1